This is a preview of subscription content, log in via an institution to check access.
Reference
Straub N, et al. A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patients. Thrombosis and Haemostasis 111: No. 2, 24 Oct 2013. Available from: URL: http://dx.doi.org/10.1160/TH13-08-0679
Rights and permissions
About this article
Cite this article
PFT-guided antiplatelet therapy cost effective in ACS. PharmacoEcon Outcomes News 692, 14 (2013). https://doi.org/10.1007/s40274-013-0912-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0912-6